MNPR vs TJX · $431.4M cap vs P/E 32, rev $29.50B
Monopar Therapeutics Inc (MNPR) versus The TJX Companies Inc (TJX) — a side-by-side from cached financials, not a winner call.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
The TJX Companies Inc (TJX) is a apparel retail company listed on NYSE. It is led by Ernie L. Herrman.
Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.
Latest reported TJX revenue for 2026-08-01 was $29.50B. Net income was $2.85B. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
MNPR currently screens at market cap $431.4M. TJX currently screens at market cap $181.32B and trailing P/E 31.9.
Not investment advice. Open the MNPR and TJX stock pages for the full models.
Not investment advice.